SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is under pressure after Gartner warned that most independent neocloud providers may not survive through 2030, intensifying concerns about the debt-funded AI infrastructure model and the companys rising borrowing costs. Traders are divided between fears of financial distress and bankruptcy and dip-buying views that its backlog and ongoing AI compute demand offer support.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

RKLBs selloff is fueling concern among traders about Neutrons progress, including speculation that the first flight could be delayed and frustration over limited updates on its Stage 1 hardware. Some see that execution uncertainty as a company-specific risk, while others point to a broader pullback in high-growth and space stocks; long-term bulls continue to cite Rocket Labs launch, satellite and defense businesses.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The FDA expanded Anktivas approval to cover high-grade papillary-only, BCG-unresponsive bladder cancer, broadening its eligible patient population ahead of the expected decision date. Traders largely view the label expansion as a major commercial and regulatory win, though many are frustrated by the stocks muted reaction and debate whether the news was already priced in or selling pressure is holding shares back.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following segments: Walmart U.S., Walmart International, and Sam's Club U.S. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club U.S. segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmarts strength against a weaker broader market is drawing attention, with traders attributing it to a rotation into defensive consumer-staples stocks alongside Costco and Target. Many are bullish and discussing call options, while others caution that the rally may be stretched and Walmarts valuation is high.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Gartners warning that most independent neocloud providers may not survive as AI infrastructure spending outpaces revenue has fueled a sharp selloff in Nebius and its peers, with inflation and rate-hike concerns adding pressure. Traders are divided between viewing the drop as a buying opportunity in an intact AI-demand story and seeing it as a sign of excessive valuations and financing risk.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMCs quarterly results and outlook are the main focus, with traders looking for confirmation that AI-chip demand can sustain growth after strong sales figures were already reported. Bulls hope the report could steady semiconductor stocks, while skeptics point to high expectations and the sector selloff as risks for a sell-the-news reaction.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

A steep selloff and fresh lows dominate discussion, with traders citing possible short pressure, dilution, and weakness across small-cap and tech stocks. Bulls point to Ondass Palantir-backed Regna AI venture and defense business updates, while skeptics question whether growth can translate into profits for shareholders.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

ASTS is under pressure amid concerns about SpaceXs expanding direct-to-phone ambitions and uncertainty over ASTs satellite launch schedule, compounded by Piper Sandlers downgrade. Traders are split between viewing the selloff as an overreaction and citing execution delays and managements lack of launch updates as reasons for further caution.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is drawing attention amid a sharp memory-stock selloff, as traders react to reports of Chinese rival CXMTs progress toward a next-generation DDR5 server-memory product alongside concerns about AI demand and Korean-market outflows. The community is divided: some see further downside from competitive and market pressures, while others call the decline overdone given SK Hynixs HBM position and ongoing AI-memory demand.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is falling alongside neocloud peers as traders react to Gartners warning that AI infrastructure spending may outstrip revenue and many independent providers may not survive; hotter inflation and financing-cost concerns are adding pressure. The community is split between seeing a sector-wide valuation reset and buying opportunity versus fearing an AI infrastructure bubble and further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CAPR if Dr Hemmati gets appointed as CBER chief, Vinay Prasad is gonna want credit  for CAPRs approval. Will beat David to the punch. Guaranteed! lol

Wendy youd

Lev Humphries

UncleB13

Nobody

RocketGLK

Natalie

Nick D

Mark Hammock

Pork fried rice

George

Stonksgoup

Audrey Link

Anderson Bond

Green_Dream

Asher

Keith

Sammy B

Tom Richter

CAPRise

StockTwits Web

StockTwits for iOS

Capricor Therapeutics Inc

 if Dr Hemmati gets appointed as CBER chief, Vinay Prasad is gonna want credit  for CAPRs approval. Will beat David to the punch. Guaranteed! lol

WBinthehouse

@WBinthehouse well, he better hurry the f up then! Lol

Steve D

StockTwits For Android 

 well, he better hurry the f up then! Lol

@Fenderstrat68 this is the basement still just like when it was $3-$5 PPS. Triple digits is coming.

 this is the basement still just like when it was $3-$5 PPS. Triple digits is coming.

@WBinthehouse 100%!! I was somewhat conservative thinking maybe 4/5 bill but could really jump higher pre revenue. I think that with approval, revenue is automatically to be calculated for two full Qs rather than Q4, and that adds to the full outlook. We know they will transition all patients from trisls to insured, and we know they have stockpiled, so I think at least 200/300 patients x2 treatments =$$$$ by eoy. But, is this optimistic ?

 100%!! I was somewhat conservative thinking maybe 4/5 bill but could really jump higher pre revenue. I think that with approval, revenue is automatically to be calculated for two full Qs rather than Q4, and that adds to the full outlook. We know they will transition all patients from trisls to insured, and we know they have stockpiled, so I think at least 200/300 patients x2 treatments =$$$$ by eoy. But, is this optimistic ?

@WBinthehouse I don&#39;t care who takes credit, to be honest. Just get this treatment approved and to these kids. Like seriously, this game has cost lives and muscle.

M_rmro

John Albrecht

Finli

 I don't care who takes credit, to be honest. Just get this treatment approved and to these kids. Like seriously, this game has cost lives and muscle.

@WBinthehouse Yeah, Prasad will be in a real jamb, because he KNOWS Deramiocel will get approved - and he will want credit for it, even though he was in fact the thorn in their side and did everything he could to deny them. His only problem: 
 
WE DO NOT FORGET.

 Yeah, Prasad will be in a real jamb, because he KNOWS Deramiocel will get approved - and he will want credit for it, even though he was in fact the thorn in their side and did everything he could to deny them. His only problem: 
 
WE DO NOT FORGET.

@NoMonkeyBusiness Prasad as a RCT stickler  wanted the P3 unblinded since it was available. Pretty much during that time Vinay was battling with Sarepta when CAPR received the CRL. Sarepta drugs got approved conditionally based on surrogate endpoints that were supposed to predict clinical benefits but became controversial with the lack of efficacy and safety concerns. VP wanted to take the regulatory rigor route.

 Prasad as a RCT stickler  wanted the P3 unblinded since it was available. Pretty much during that time Vinay was battling with Sarepta when CAPR received the CRL. Sarepta drugs got approved conditionally based on surrogate endpoints that were supposed to predict clinical benefits but became controversial with the lack of efficacy and safety concerns. VP wanted to take the regulatory rigor route.